Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì
  #1  
Ñòàðûé 30.03.2012, 02:54
Elena_spb Elena_spb âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 10.11.2009
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 12
Ñêàçàë(à) ñïàñèáî: 6
Elena_spb *
Ìîíîíóêëåîç ëè ýòî?

Óâàæàåìûå ñïåöèàëèñòû!
Ñèòóàöèÿ òàêîâà: äåâî÷êà, 5 ëåò, ðîñò 103,5 ñì, âåñ 12.500, öåëèàêèÿ êëèíè÷åñêè (ïîëíîå îáñëåäîâàíèå ïî êðîâè íå ïîäòâåðäèëî äèàãíîç, áèîïñèþ íå äåëàëè), 3 ãîäà íà áåçãëþòåíîâîé äèåòå.
 íà÷àëå ìàðòà çàáîëåëà, áûëî ïîõîæå íà áàíàëüíîå ÎÐÂÈ (áîëååò 1-2 ðàçà â ãîä), äàâàëè îáèëüíîå ïèòüå, Àêâàìàðèñ â íîñ, íàõîäèëèñü äîìà, íî òåìïåðàòóðà óïîðíî äåðæàëàñü 38-39 â òå÷åíèå 5 äíåé (ðåáåíîê òåìïåðàòóðó ïåðåíîñèò õîðîøî), íà÷àëñÿ ãëóáîêèé ëàþùèé êàøåëü è ñèëüíûé õðàï íî÷üþ – ìû âûçâàëè ïåäèàòðà. Îí óñòàíîâèë óâåëè÷åíèå ïå÷åíè, øåéíûõ ëèìôàòè÷åñêèõ óçëîâ, çàïîäîçðèë ïíåâìîíèþ êàê îñëîæíåíèå èíôåêöèîííîãî ìîíîíóêëåîçà. Ïîïóòíî áûë ïîñòàâëåí äèàãíîç ëàêóíàðíîé àíãèíû è ðåàêòèâíîãî àðòðèòà êîëåííûõ ñóñòàâîâ (ñèëüíàÿ áîëü, ðàñïóõëè). Íàçíà÷èëè ìíîãî àíàëèçîâ, ðåíòãåí ëåãêèõ. Äâóõñòîðîííÿÿ î÷àãîâàÿ ïíåâìîíèÿ áûëà ïîäòâåðæäåíà ðåíòãåíîì â äâóõ ïðîåêöèÿõ è îñìîòðîì ôòèçèàòðà â ïðîòèâîòóáåðêóëåçíîì äèñïàíñåðå. Ðåçóëüòàòû íàçíà÷åííûõ àíàëèçîâ òàêîâû:
Ìàçîê èç ðîòîãëîòêè:
Epstein-Barr Virus, ÄÍÊ (+)
Âåíîçíàÿ êðîâü:
Cytomegalovirus, ÄÍÊ (-)
Human Herpes Virus 6, ÄÍÊ (-)
Epstein-Barr Virus, ÄÍÊ (++)
Epstein-Barr Virus êàïñèäíûé áåëîê (VCA), IgM
Îòíîøåíèå S/CO (signal/cutoff) 0.10 (0 - 0.9), ðåçóëüòàò îòðèöàòåëüíûé
Herpes Simplex Virus 1/2, IgG 0.205 ( 0 - 0.9), ðåçóëüòàò îòðèöàòåëüíûé
Herpes Simplex Virus 1/2, IgM ðåçóëüòàò îòðèöàòåëüíûé
Human Herpes Virus 6, IgG 1.43 (0 - 0.79), ðåçóëüòàò ïîëîæèòåëüíûé
Epstein-Barr Virus ðàííèå àíòèãåíû (EA), IgG, ðåçóëüòàò îòðèöàòåëüíûé
Epstein-Barr Virus ÿäåðíûé àíòèãåí (EBNA), IgG (êîëè÷åñòâåííî) 164.2 Åä/ìë,
ðåçóëüòàò ïîëîæèòåëüíûé
Cytomegalovirus, IgM (êîëè÷åñòâåííî) 0.14 AU/ml (0 - 0.9), ðåçóëüòàò îòðèöàòåëüíûé
Cytomegalovirus, IgG (êîëè÷åñòâåííî) 11.80 Åä/ìë (0 - 0.9), ðåçóëüòàò ïîëîæèòåëüíûé
Àëàíèíàìèíîòðàíñôåðàçà (ÀËÒ) 22.60 Åä/ë (0 – 35)
Àñïàðòàòàìèíîòðàíñôåðàçà (ÀÑÒ) 52.00 Åä/ë (15 – 60)
Áèëèðóáèí îáùèé 9.64 ìêìîëü/ë (5 – 21)
Áèëèðóáèí ïðÿìîé1.68 ìêìîëü/ë (0 - 3.4)
Îáùåêëèíè÷åñêèé àíàëèç êðîâè (23 ïîêàçàòåëÿ):
Ëåéêîöèòû (WBC) 8.43 *10^9/ë (5 - 14.5)
Ýðèòðîöèòû (RBC) 4.77 *10^12/ë (3.7 - 4.9)
Ãåìîãëîáèí (HGB) 128 ã/ë (115 – 145)
Ãåìàòîêðèò (HTC) 38.0 % (32 – 42)
Ñðåäíèé îáúåì ýðèòðîöèòà (MCV) 79.7 fL (75 – 87)
Ñðåäí. ñîä. ãåìîãëîáèíà â ýð-òå (MCH) 26.8 ïã (25 – 31)
Ñðåäí. êîíö. ãåìîãëîáèíà â ýð-òå (MCHC) 337 ã/ë (320 – 370)
Òðîìáîöèòû (PLT) 291 *10^9/ë (180 – 450)
Ðàñïð. ýðèò. ïî V - ñòàíä îòêëîí(RDW-SD) 36.6 fL (37.2 - 54.2)
Ðàñïð. ýðèò. ïî V - êîýô. âàðèàö(RDW-CV) 12.9 % (11.3 - 19.5)
Ðàñïð. òðîìáîöèòîâ ïî îáúåìó (PDW) 9.3 fL (10 – 20)
Ñðåäíèé îáúåì òðîìáîöèòà (MPV) 9.00 fL (9.4 - 12.4)
Êîýôôèöèåíò áîëüøèõ òðîìáîöèòîâ (P-LCR) 17.3 % (13 – 43)
Íåéòðîôèëû (NE) 4.19 *10^9/ë (1.56 - 6.13)
Ëèìôîöèòû (LY) 3.09 *10^9/ë (2.0 - 8.0)
Ìîíîöèòû (MO) 0.70 *10^9/ë (0.24 - 0.56)
Ýîçèíîôèëû (EO) 0.42 *10^9/ë (0.04 - 0.36)
Áàçîôèëû (BA) 0.03 *10^9/ë (0 - 0.08)
Íåéòðîôèëû, % (NE%) 49.6 % (38 – 58)
Ëèìôîöèòû, % (LY%) 36.7 % (30 – 50)
Ìîíîöèòû, % (MO%) 8.3 % (3 – 9)
Ýîçèíîôèëû, % (EO%) 5.0 % (1 – 5)
Áàçîôèëû, % (BA%) 0.4 % (0 - 1.2)
Ñêîðîñòü îñåäàíèÿ ýðèòðîöèòîâ (ÑÎÝ)
Ñêîðîñòü îñåäàíèÿ 6 ìì/÷ (2 – 15)
Ðåòèêóëîöèòû
Ðåòèêóëîöèòû, % (RET%) 0.3 % (0.2 - 0.7)
Ðåòèêóëîöèòû (RET#) 14.3 *10^9/ë (17.0 - 63.8)
Ôðàêöèÿ íåçðåëûõ ðåòèêóëîöèòîâ (IRF) 1.4 % (3 - 15.9)
Ôðàêöèÿ íèçêîé ôëþîðåñöåíöèè (LFR) 98.6 % (83 – 97)
Ôðàêöèÿ ñðåäíåé ôëþîðåñöåíöèè (MFR) 1.4 % (2.9 - 15.9)

Ãëþêîçà â ïëàçìå 4.06 ììîëü/ë (3.3 - 5.5)
Ñ-ðåàêòèâíûé áåëîê, êîëè÷åñòâåííî 0.05 ìã/ë (0 – 1)
Ðåâìàòîèäíûé ôàêòîð 3.41 ÌÅ/ìë (0 – 14)
Àíòèñòðåïòîëèçèí-Î 3.28 ÌÅ/ìë (0 – 150)
Áåëêîâûå ôðàêöèè â ñûâîðîòêå:
Îáùèé áåëîê 72.0 ã/ë (57 – 80)
Àëüáóìèí 40.5 ã/ë
Àëüáóìèí, % 56.2 % (58 – 70)
Àëüôà-1 ãëîáóëèí 2.5 ã/ë
Àëüôà-1 ãëîáóëèí, % 3.5 % (1.5 - 4.0)
Àëüôà-2 ãëîáóëèí 11.1 ã/ë
Àëüôà-2 ãëîáóëèí, % 15.4 % (5.0 - 10.0)
Áåòà-ãëîáóëèí 6.6 ã/ë
Áåòà-ãëîáóëèí, % 9.2 % (7.0 - 13.0)
Ãàììà-ãëîáóëèí 11.4 ã/ë
Ãàììà-ãëîáóëèí, % 15.8 % (10.0 - 19.0)

Îáùèé àíàëèç ìî÷è â íîðìå
Àíàëèç êàëà íà ÿ/ãëèñò è öèñòû ïðîñòåéøèõ îòðèöàòåëüíûé
Àíàëèç êàëà íà ÀÃ ëÿìáëèé îòðèöàòåëüíûé

Íàçíà÷åíî ëå÷åíèå: çèííàò íà 14 äíåé, ãåíôåðîí íà 10 äíåé, íóðîôåí íà 7 äíåé, êëàðèòèí íà 7 äíåé, ÀÖÖ 100 5 äíåé, çàòåì ëàçîëâàí, àöèïîë, âèáðîöèë, ôóêîðöèí, çîñòåðèí-óëüòðà, ïîëèâèòàìèíû. Âñå âûïîëíèëè.

Íà äàííûé ìîìåíò ïîñòàâëåí äèàãíîç: èíôåêöèîííûé ìîíîíóêëåîç ñòàäèÿ ïîçäíåãî îñòðîãî ïåðèîäà, îñòàòî÷íûå ÿâëåíèÿ äâóõñòîðîííåé î÷àãîâîé ïíåâìîíèè, ðåàêòèâíûé àðòðèò.
Òåìïåðàòóðû è êàøëÿ íåò äàâíî, ãîðëî îò ôóêîðöèíà ïðîøëî íà òðåòèé äåíü, çàëîæåííîñòü íîñà ïðàêòè÷åñêè èñ÷åçëà, êîëåíè ïðèøëè â íîðìó, íî îäíà êîëåíêà ïîáàëèâàåò. Ðåáåíîê âÿëûé, êàïðèçíûé, ìíîãî ïüåò, ïðîñèò êèñëåíüêîãî, ïîÿâèëñÿ íåïðèÿòíûé çàïàõ èçî ðòà (ñòîìàòîëîã ñìîòðåë íàêàíóíå áîëåçíè, âñå â ïîðÿäêå), äåðìàòèò íà çàïÿñòüÿõ.
Íîâûå íàçíà÷åíèÿ: öèêëîôåðîí ïî ñõåìå, íåéðîìóëüòèâèò, àöèïîë ïðîäîëæàòü, íóðîôåí ïðîäîëæàòü, êñèçàë, ãàëñòåíà, ýëüêàð. Ñíîâà ñäàâàòü ìàçîê èç ðîòîãëîòêè íà ÂÝÁ.
ß ÷èòàëà ìàòåðèàëû ôîðóìà, íàçíà÷åíèå öèêëîôåðîíà ìåíÿ î÷åíü ñìóùàåò.
Åñòü ëè ñìûñë åùå ðàç ñäàâàòü ìàçîê èç ðîòîãëîòêè? (Ïðåäûäóùèé ìàçîê ñäàâàëè äâå íåäåëè íàçàä).
È áûë ëè ó íàñ íà ñàìîì äåëå ìîíîíóêëåîç?
Ïîæàëóéñòà, ïîìîãèòå ðàçîáðàòüñÿ.

Çàðàíåå áëàãîäàðþ çà îòâåò.
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 30.03.2012, 10:56
nbianki nbianki âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 23.04.2009
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 808
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 334 ðàç(à) çà 309 ñîîáùåíèé
nbianki ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånbianki ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånbianki ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånbianki ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånbianki ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånbianki ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ÌÎíîíóêëåîç áûë. Ïðî ïíåâìîíèþ - íåèçâåñòíî, íóæíî âûëîæèòü ðåíòãåíîãðàììó.
"öèêëîôåðîí ïî ñõåìå, íåéðîìóëüòèâèò, àöèïîë ïðîäîëæàòü, íóðîôåí ïðîäîëæàòü, êñèçàë, ãàëñòåíà, ýëüêàð. Ñíîâà ñäàâàòü ìàçîê èç ðîòîãëîòêè íà ÂÝÁ." - ÂÎÒ ÝÒÎ ÂÑÅ ÍÅ ÍÀÄÎ.
"Òåìïåðàòóðû è êàøëÿ íåò äàâíî, ãîðëî îò ôóêîðöèíà ïðîøëî íà òðåòèé äåíü, çàëîæåííîñòü íîñà ïðàêòè÷åñêè èñ÷åçëà, êîëåíè ïðèøëè â íîðìó" - ÝÒÎ ÃËÀÂÍÎÅ. íà ìîé âçãëÿä, ëå÷åíèå óæå íå íóæíî íèêàêîå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 30.03.2012, 13:29
Elena_spb Elena_spb âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 10.11.2009
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 12
Ñêàçàë(à) ñïàñèáî: 6
Elena_spb *
Ê ñîæàëåíèþ, ñíèìêè ó ìåíÿ âûëîæèòü íå ïîëó÷àåòñÿ, ìîãó òîëüêî ïðèâåñòè îïèñàíèå ôòèçèàòðà:
«Íà îáçîðíîé è ïðàâîé áîêîâîé RG-ãðàììàõ â S7 ñïðàâà ó÷àñòêè èíôèëüòðàöèè ïî õîäó ñãóùåííîãî ëåãî÷íîãî ðèñóíêà, ëåãî÷íûé ðèñóíîê ñãóùåí â S10 ñïðàâà.  îñòàëüíûõ îòäåëàõ áåç î÷àãîâûõ è èíôèëüòðàòèâíûõ èçìåíåíèé. Êîðíè ñòðóêòóðíû. Ñèíóñû ñâîáîäíû. Äèàôðàãìà î÷åð÷åíà. Êîíòðîëü ïîñëå ïðîòèâîïíåâìîíè÷åñêîé òåðàïèè ÷åðåç 14 äíåé»
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 30.03.2012, 14:40
nbianki nbianki âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 23.04.2009
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 808
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 334 ðàç(à) çà 309 ñîîáùåíèé
nbianki ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånbianki ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånbianki ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånbianki ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånbianki ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìånbianki ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ñåé÷àñ âñå ðàâíî íå íóæíî óæå íè÷åì ëå÷èòü ïíåâìîíèþ, âñå ïîçàäè.
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 30.03.2012, 15:10
Elena_spb Elena_spb âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 10.11.2009
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 12
Ñêàçàë(à) ñïàñèáî: 6
Elena_spb *
ïåäèàòð íàñòàèâàåò íà ïîâòîðíîì ðåíòãåíå ëåãêèõ, åñòü ëè ñìûñë åãî äåëàòü åùå ðàç? íå õî÷åòñÿ ëèøíèé ðàç îáëó÷àòü ðåáåíêà è âîçèòü â ïðîòèâîòóáåðêóëåçíûé äèñïàíñåð (íàïðàâëåíèå òóäà)
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 06.04.2012, 17:20
dberez dberez âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 06.04.2012
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 120
Ñêàçàë(à) ñïàñèáî: 3
Ïîáëàãîäàðèëè 15 ðàç(à) çà 14 ñîîáùåíèé
dberez ýòîò ó÷àñòíèê èìååò îòâðàòèòåëüíóþ ðåïóòàöèþ íà ôîðóìå
Ñäåëàéòå. Âðåäà íå áóäåò.
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 08.04.2012, 02:13
Elena_spb Elena_spb âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 10.11.2009
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 12
Ñêàçàë(à) ñïàñèáî: 6
Elena_spb *
Óâàæàåìûå ñïåöèàëèñòû!

Íàø ïîñëåäíèé ÎÀÊ îò 04.04.2012 òàêîâ:

Ëåéêîöèòû (WBC) 8.09 *10^9/ë 5 - 14.5
Ýðèòðîöèòû (RBC) 4.60 *10^12/ë 3.7 - 4.9
Ãåìîãëîáèí (HGB) 122 ã/ë 115 - 145
Ãåìàòîêðèò (HTC) 35.4 % 32 - 42
Ñðåäíèé îáúåì ýðèòðîöèòà (MCV) 77.0 fL 75 - 87
Ñðåäí. ñîä. ãåìîãëîáèíà â ýð-òå (MCH) 26.5 ïã 25 - 31
Ñðåäí. êîíö. ãåìîãëîáèíà â ýð-òå (MCHC) 345 ã/ë 320 - 370
Òðîìáîöèòû (PLT) 260 *10^9/ë 180 - 450
Ðàñïð. ýðèò. ïî V - ñòàíä îòêëîí(RDW-SD) 37.5 fL 37.2 - 54.2
Ðàñïð. ýðèò. ïî V - êîýô. âàðèàö(RDW-CV) 13.6 % 11.3 - 19.5
Ðàñïð. òðîìáîöèòîâ ïî îáúåìó (PDW) ↓ 9.9 fL 10 - 20
Ñðåäíèé îáúåì òðîìáîöèòà (MPV) ↓ 9.30 fL 9.4 - 12.4
Êîýôôèöèåíò áîëüøèõ òðîìáîöèòîâ (P-LCR) 19.4 % 13 - 43
Íåéòðîôèëû (NE) ↓ 1.48 *10^9/ë 1.56 - 6.13
Ëèìôîöèòû (LY) 5.59 *10^9/ë 2.0 - 8.0
Ìîíîöèòû (MO) ↑ 0.66 *10^9/ë 0.24 - 0.56
Ýîçèíîôèëû (EO) 0.32 *10^9/ë 0.04 - 0.36
Áàçîôèëû (BA) 0.04 *10^9/ë 0 - 0.08
Íåéòðîôèëû, % (NE%) ↓ 18.2 % 38 - 58
Ëèìôîöèòû, % (LY%) ↑ 69.1 % 30 - 50
Ìîíîöèòû, % (MO%) 8.2 % 3 - 9
Ýîçèíîôèëû, % (EO%) 4.0 % 1 - 5
Áàçîôèëû, % (BA%) 0.5 % 0 - 1.2
Íåéòðîôèëû, % (NE%) (ìèêðîñêîïèÿ) ↓ 31 % 38 - 58
Íåéòðîôèëû: ïàëî÷ê. (ìèêðîñêîïèÿ) 3 % 1 - 6
Íåéòðîôèëû: ñåãìåíò. (ìèêðîñêîïèÿ) ↓ 28 % 38 - 58
Ëèìôîöèòû, % (LY%) (ìèêðîñêîïèÿ) ↑ 60 % 30 - 50
Ìîíîöèòû, % (MO%) (ìèêðîñêîïèÿ) 5 % 3 - 9
Ýîçèíîôèëû, % (EO%) (ìèêðîñêîïèÿ) 4 % 1 - 5
Áàçîôèëû, % (BA%) (ìèêðîñêîïèÿ) 0 % 0 - 1.2
Ñêîðîñòü îñåäàíèÿ ýðèòðîöèòîâ (ÑÎÝ)
Ñêîðîñòü îñåäàíèÿ 5 ìì/÷ 2 - 15
Ðåòèêóëîöèòû
Ðåòèêóëîöèòû, % (RET%) ↑ 0.8 % 0.2 - 0.7
Ðåòèêóëîöèòû (RET#) 35.0 *10^9/ë 17.0 - 63.8
Ôðàêöèÿ íåçðåëûõ ðåòèêóëîöèòîâ (IRF) 5.8 % 3 - 15.9
Ôðàêöèÿ íèçêîé ôëþîðåñöåíöèè (LFR) 94.2 % 83 - 97
Ôðàêöèÿ ñðåäíåé ôëþîðåñöåíöèè (MFR) 5.8 % 2.9 - 15.9
Ôðàêöèÿ âûñîêîé ôëþîðåñöåíöèè (HFR) 0.0 % 0 - 1.7

Ïåäèàòð íàñòîé÷èâî ïðîñèò ñäàòü àíàëèç íà îïðåäåëåíèå àíòèòåë ê ÂÈ× òèïîâ 1 è 2, ÷òîáû çàòåì îòïðàâèòü íàñ ê èììóíîëîãó íà 6 ìåñ ïîä íàáëþäåíèå, îáúÿñíÿÿ, ÷òî ýòî ñòàíäàðò âåäåíèÿ áîëüíûõ, âûçäîðàâëèâàþùèõ ïîñëå èíôåêöèîííîãî ìîíîíóêëåîçà.

Ýòî, äåéñòâèòåëüíî, îáùåïðèíÿòûé ñòàíäàðò, äàæå â ïåäèàòðèè?
Åñòü ëè íåîáõîäèìîñòü â äàííîì àíàëèçå?
Èìååò ëè ñìûñë âîîáùå íàáëþäàòüñÿ ó èììóíîëîãà, ñóäÿ ïî íàøåìó ïîñëåäíåìó ÎÀÊ?
Çàðàíåå áëàãîäàðþ çà îòâåòû.
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 08.04.2012, 02:21
Elena_spb Elena_spb âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 10.11.2009
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 12
Ñêàçàë(à) ñïàñèáî: 6
Elena_spb *
Ó ðåáåíêà ñîõðàíÿåòñÿ òîëüêî ëåãêàÿ çàëîæåííîñòü íîñà è äåðìàòèò íà çàïÿñòüÿõ, êîòîðûé ïîÿâèëñÿ ñ íà÷àëîì ïðèåìà çèííàòà/ãåíôåðîíà (äåðìàòèò - ðåäêàÿ äëÿ íàñ ðåàêöèÿ). Àïïåòèò è íàñòðîåíèå õîðîøèå, ÓÇÈ îðãàíîâ áðþøíîé ïîëîñòè è ïî÷åê, ÎÀÌ òàêæå îò 04.04.2012 â íîðìå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 08.04.2012, 03:16
Àâàòàð äëÿ antibiotik
antibiotik antibiotik âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 07.02.2006
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 4,486
Ïîáëàãîäàðèëè 2,017 ðàç(à) çà 1,347 ñîîáùåíèé
antibiotik ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåantibiotik ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåantibiotik ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåantibiotik ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåantibiotik ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåantibiotik ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåantibiotik ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåantibiotik ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåantibiotik ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåantibiotik ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåantibiotik ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïîäòâåðæäåííûé àíòèòåëàìè èíôåêöèîííûé ìîíîíóêëåîç íå òðåáóåò îáñëåäîâàíèÿ íà ÂÈ×. Ðàíüøå áûëà òàêàÿ óñòàíîâêà, íî ýòî èçáûòî÷íî è íå íóæíî.
Àíàëèç êðîâè - íîðìàëüíûé, õàðàêòåðíûé äëÿ ïåðåíåñåííîé íåäàâíî âèðóñíîé èíôåêöèè. Èììóíîëîã íå íóæåí, ïðèçíàêîâ èììóíîäåôèöèòà íåò.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 14:16.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.